-
-
-
-
-
-
-
NewAmsterdam Pharma Appoints Janneke van der Kamp to its Board of Directors
-
-
-
-
-
-
-
NewAmsterdam Announces Positive Results from ROSE2, Phase 2 Trial Evaluating Obicetrapib in Combination with Ezetimibe as an Adjunct to High-Intensity Statin Therapy
-
-
14,665 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

